Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | MAPT | P10636 | 7/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6324227 | 0.97 | MAPT (0.43) | ALDH1A1MAPTHPGDNPC1KMT2A | |
| SCHEMBL6325373 | 0.97 | MAPT (0.43) | ALDH1A1MAPTHPGDNPC1KMT2A | |
| SCHEMBL9951514 | 0.88 | MAPT (0.41) | ALDH1A1MAPTHPGDNPC1KMT2A | |
| SCHEMBL8249007 | 0.82 | ALDH1A1 (0.37) | ALDH1A1MAPTKMT2ANOS3NOS1 | |
| SCHEMBL10939624 | 0.76 | CA1 (0.35) | ALDH1A1KMT2ANOS3NOS1NOS2 | |
| SCHEMBL8074257 | 0.75 | MAPT (0.32) | ALDH1A1MAPTHPGDNOS3NOS1 | |
| SCHEMBL11420025 | 0.75 | MAPT (0.32) | ALDH1A1MAPTHPGDNPC1NOS3 | |
| SCHEMBL11898062 | 0.73 | — | — | |
| SCHEMBL11276638 | 0.73 | KMT2A (0.45) | MAPTNPC1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL22562098 | 0.73 | ALDH1A1 (0.33) | ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1260572-B1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | ZEON CORP (JP) | 2006-05-03 | — | — | EP | claimed |
| US-6653276-B2 | A cyclopentanone or cyclopentanol compound having 2,5-dicyclopentylidene substituents, 2,5- dicyclopentyl substituents or 2-cyclopentylidene-5-cyclopentyl substituents; useful as perfume emitting floral fragrance | ZEON CORPORATION (JP) | 2003-11-25 | — | — | US | claimed |
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | ZEON CORPORATION (JP) | 2003-01-16 | — | — | US | claimed |
| EP-1260572-A1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | Zeon Corporation (JP) | 2002-11-27 | — | — | EP | claimed |
| CN-115286776-B | Preparation method of polybutylene adipate/terephthalate | 富海(东营)新材料科技有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-115286776-A | Preparation method of polybutylene adipate/terephthalate | 富海(东营)新材料科技有限公司 | 2022-11-04 | — | — | CN | disclosed |
| US-20070027061-A1 | Perfume compositions and 3,6-dicyclopentyl-ò-valero-lactone | ZEON CORPORATION (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20070027061-A1 | Perfume compositions and 3,6-dicyclopentyl-ò-valero-lactone | ZEON CORPORATION (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20070027061-A1 | Perfume compositions and 3,6-dicyclopentyl-ò-valero-lactone | ZEON CORPORATION (JP) | 2007-02-01 | — | — | US | disclosed |
| EP-1260572-B1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | ZEON CORP (JP) | 2006-05-03 | — | — | EP | disclosed |
| EP-1609845-A1 | PERFUME COMPOSITIONS AND 3,6-DICYCLOPENTYL-DELTA-VALERO- LACTONE | ZEON CORPORATION (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-6653276-B2 | A cyclopentanone or cyclopentanol compound having 2,5-dicyclopentylidene substituents, 2,5- dicyclopentyl substituents or 2-cyclopentylidene-5-cyclopentyl substituents; useful as perfume emitting floral fragrance | ZEON CORPORATION (JP) | 2003-11-25 | — | — | US | disclosed |
| US-6653276-B2 | A cyclopentanone or cyclopentanol compound having 2,5-dicyclopentylidene substituents, 2,5- dicyclopentyl substituents or 2-cyclopentylidene-5-cyclopentyl substituents; useful as perfume emitting floral fragrance | ZEON CORPORATION (JP) | 2003-11-25 | — | — | US | disclosed |
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | ZEON CORPORATION (JP) | 2003-01-16 | — | — | US | disclosed |
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | ZEON CORPORATION (JP) | 2003-01-16 | — | — | US | disclosed |
| EP-1260572-A1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | Zeon Corporation (JP) | 2002-11-27 | — | — | EP | disclosed |
| EP-1260572-A1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | Zeon Corporation (JP) | 2002-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | DHPS, DOHH, PORCN | ALDH1A1 1835/4885MAPT 3601/4885HPGD 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.